Cellular mechanisms associated with the lack of chronic thermotolerance expression in HeLa S3 cells.

Chronic thermotolerance is an operational definition for that resistance to cell killing by heat which develops during a protracted exposure at temperatures generally in the range of 41.5-42.5 degrees C which is usually observed as a reduction in the slope of the survival curve. While Chinese hamster ovary (CHO) cells are generally more sensitive to high-temperature heat shock than HeLa cells, studies of cells maintained in suspension culture at 41.5 degrees C demonstrated CHO cells to be more resistant to cell killing at this temperature than HeLa cells, due to the expression of chronic thermotolerance in the hamster cell line and the corresponding lack of chronic thermotolerance expression in the HeLa cell line. Experiments were conducted in the two cell lines while heating under identical conditions, in order to detect any cell line-specific changes in heat-induced perturbation of cell cycle progression and the expression of chronic thermotolerance. Our results showed that CHO cells exhibited a G1 block which lasted throughout the course of the 32-h heating period. HeLa cells, however, failed to accumulate in G1, progressing instead into S phase where spontaneous premature chromosome condensation and nuclear fragmentation were observed. This accumulation of cells with condensed chromatin possessing S-phase DNA content exhibited a linear, one-to-one functional relationship with the fraction of dead cells. Previous studies (M.A. Mackey and W.C. Dewey, Int. J. Hyperthermia, 5:405-415, 1989) demonstrated that synchronized S-phase CHO cells heated at 41.5 degrees C and 42 degrees C were unable to express chronic thermotolerance. Therefore, we hypothesize that progression of cells out of G1 phase into S and G2-M phases leads to lethal processes that prevent the expression of chronic thermotolerance in the HeLa cell line. This hypothesis is strengthened by the observed correlation between the accumulation of "mitotic-like" cells and decreased survival, suggesting that the G1 block observed in CHO cells is causally connected with the expression of chronic thermotolerance.

Changes in heat and radiation sensitivity during long duration, moderate hyperthermia in HeLa S3 cells.

Step-up heating and thermal radiosensitization were studied at 41.5 degrees C in HeLa S3 cells under conditions where chronic thermotolerance was not expressed. In spite of this lack of thermotolerance expression, it was possible that thermotolerance to higher temperature treatment had developed. Accordingly, cells were incubated for various times at 41.5 degrees C, then immediately shifted up to 45 degrees C, whereupon heating continued for up to 75 min. Thermotolerance to 45 degrees C heating was observed after 8 hr incubation at 41.5 degrees C and decayed by 32 hr of continuous incubation at 41.5 degrees C. When the time of 45 degrees C treatment was extended to 150 min, the biphasic survival response indicated that chronic thermotolerance was expressed at 45 degrees C, even though it was not expressed during the 41.5 degrees C treatment. Thus, chronic thermotolerance can develop under conditions (e.g., at 41.5 degrees C) where it is not expressed, yet be expressed under other conditions (e.g., during 45 degrees C exposure). When cultures were x-irradiated after various periods of 41.5 degrees C treatment, maximum thermal radiosensitization was observed after 4 hr of incubation at 41.5 degrees C, for which no cell killing was observed due to heat alone. The radiosensitization observed decreased the Do and Dq values from about 1.3 Gy to 0.7 Gy and from about 2.0 Gy to 1.0 Gy, respectively. As the duration of the 41.5 degrees C pre-treatment was extended up to 32 hr, no additional thermal-radiosensitization was observed; all killing due to the heat exposure at 41.5 degrees C was additive to the radiation killing after the initial induction of thermal radiosensitization. These results demonstrate differences in the thermal and radiation responses of HeLa cells when compared to earlier studies using CHO cells and may be more relevant to the clinical setting.